Assenagon Asset Management
PRAX icon

Assenagon Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

Assenagon Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-408,787
Closed -$120M – 1199
2025
Q4 		$120M Sell
408,787
-992
-0.2% -$185K 0.17% 104
2025
Q3 		$21.7M Sell
409,779
-194,519
-32% -$9.43M 0.03% 350
2025
Q2 		$25.4M Buy
604,298
+96,898
+19% +$3.69M 0.04% 319
2025
Q1 		$19.2M Sell
507,400
-51,682
-9% -$3.23M 0.03% 333
2024
Q4 		$43M Buy
559,082
+548,986
+5,438% +$39.7M 0.07% 231
2024
Q3 		$581K Sell
10,096
-9,665
-49% -$522K ﹤0.01% 1223
2024
Q2 		$817K Sell
19,761
-51,492
-72% -$2.43M ﹤0.01% 1143
2024
Q1 		$4.35M Buy
+71,253
New +$3.2M 0.01% 640

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Assenagon Asset Management's PRAX Position: Q1 2026 in Review

Assenagon Asset Management sold out of Praxis Precision Medicines (PRAX) in Q1 2026, closing a stake of 408,787 shares — an estimated $120M sold.

Assenagon Asset Management first reported a position in PRAX in Q1 2024 and held it in 8 quarters. The position peaked at $120M in Q4 2025. 291 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Assenagon Asset Management reported no remaining Praxis Precision Medicines position as of Q1 2026 after selling out during the quarter.
  • Assenagon Asset Management sold 408,787 Praxis Precision Medicines shares in Q1 2026, an estimated $120M.
  • Assenagon Asset Management first reported a position in Praxis Precision Medicines in Q1 2024 and held it in 8 quarters.
  • Assenagon Asset Management's Praxis Precision Medicines position peaked at $120M in Q4 2025.
  • 291 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Assenagon Asset Management's 13F filing for Q1 2026, filed 20 Apr 2026.